Two Sigma Advisers’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,800
Closed -$68.6K 1141
2025
Q4
$68.6K Buy
+11,800
New +$56.5K ﹤0.01% 2261
2022
Q1
Sell
-12,000
Closed -$36K 2820
2021
Q4
$36K Sell
12,000
-3,300
-22% -$10.1K ﹤0.01% 2507
2021
Q3
$44K Sell
15,300
-28,600
-65% -$94.6K ﹤0.01% 2378
2021
Q2
$203K Buy
43,900
+9,000
+26% +$35.3K ﹤0.01% 2268
2021
Q1
$123K Buy
34,900
+19,800
+131% +$85.8K ﹤0.01% 2423
2020
Q4
$91K Buy
+15,100
New +$84.5K ﹤0.01% 2279
2020
Q3
Sell
-16,900
Closed -$152K 2528
2020
Q2
$152K Sell
16,900
-2,900
-15% -$29.3K ﹤0.01% 2302
2020
Q1
$149K Buy
+19,800
New +$133K ﹤0.01% 2241

Other funds holding KRMD

Two Sigma Advisers's KRMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of KORU Medical Systems (KRMD) in Q1 2026, closing a stake of 11,800 shares — an estimated $68.6K sold.

Two Sigma Advisers first reported a position in KRMD in Q1 2020 and held it in 8 quarters. The position peaked at $203K in Q2 2021. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Two Sigma Advisers reported no remaining KORU Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 11,800 KORU Medical Systems shares in Q1 2026, an estimated $68.6K.
  • Two Sigma Advisers first reported a position in KORU Medical Systems in Q1 2020 and held it in 8 quarters.
  • Two Sigma Advisers's KORU Medical Systems position peaked at $203K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.